首页> 外文期刊>Diabetes >Reducing RIP140 Expression in Macrophage Alters ATM Infiltration, Facilitates White Adipose Tissue Browning, and Prevents High-Fat Diet-Induced Insulin Resistance
【24h】

Reducing RIP140 Expression in Macrophage Alters ATM Infiltration, Facilitates White Adipose Tissue Browning, and Prevents High-Fat Diet-Induced Insulin Resistance

机译:减少巨噬细胞中RIP140的表达可改变ATM浸润,促进白色脂肪组织褐变并防止高脂饮食诱导的胰岛素抵抗

获取原文
获取原文并翻译 | 示例
       

摘要

Adipose tissue macrophage (ATM) recruitment and activation play a critical role in obesity-induced inflammation and insulin resistance (IR). The mechanism regulating ATM activation and infiltration remains unclear. In this study, we found receptor interacting protein 140 (RIP140) can regulate the dynamics of ATM that contribute to adipose tissue remodeling. A high-fat diet (HFD) elevates RIP140 expression in macrophages. We generated mice with RIP140 knockdown in macrophages using transgenic and bone marrow transplantation procedures to blunt HFD-induced elevation in RIP140. We detected significant white adipose tissue (WAT) browning and improved systemic insulin sensitivity in these mice, particularly under an HFD feeding. These mice have decreased circulating monocyte population and altered ATM profile in WAT (a dramatic reduction in inflammatory classically activated macrophages [M1] and expansion in alternatively activated macrophages [M2]), which could improve HFD-induced IR. These studies suggest that reducing RIP140 expression in monocytes/macrophages can be a new therapeutic strategy in treating HFD-induced and inflammation-related diseases.
机译:脂肪组织巨噬细胞(ATM)的募集和激活在肥胖引起的炎症和胰岛素抵抗(IR)中起关键作用。调节ATM激活和渗透的机制仍不清楚。在这项研究中,我们发现受体相互作用蛋白140(RIP140)可以调节ATM的动力学,从而促进脂肪组织的重塑。高脂饮食(HFD)可提高巨噬细胞中RIP140的表达。我们使用转基因和骨髓移植程序通过钝化HFD诱导的RIP140升高,在巨噬细胞中产生了具有RIP140敲低的小鼠。我们在这些小鼠中检测到明显的白色脂肪组织(WAT)褐变并改善了系统胰岛素敏感性,尤其是在HFD喂养下。这些小鼠的循环单核细胞数量减少,WAT中的ATM谱改变(炎性经典激活的巨噬细胞[M1]显着减少,交替激活的巨噬细胞[M2]扩展),可以改善HFD诱导的IR。这些研究表明,降低单核细胞/巨噬细胞中RIP140的表达可能是治疗HFD引起的炎症相关疾病的新治疗策略。

著录项

  • 来源
    《Diabetes》 |2014年第12期|4021-4031|共11页
  • 作者单位

    Department of Pharmacology, University of Minnesota Medical School, Minneapolis, MN;

    Department of Pharmacology, University of Minnesota Medical School, Minneapolis, MN;

    Department of Pharmacology, University of Minnesota Medical School, Minneapolis, MN;

    Endocrine Research Unit, Mayo Clinic, Rochester, MN;

    Endocrine Research Unit, Mayo Clinic, Rochester, MN;

    Department of Pharmacology, University of Minnesota Medical School, Minneapolis, MN;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:46:19

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号